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Using creative co-design to develop a
decision support tool for people with
malignant pleural effusion
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Anna Morley4, Jayne Holme6, Judith Lyons6, Maryam Ahmed6, Susan Jackson6, Deirdre Wallace5, Farinaz Noorzad5,
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Abstract
Background: Malignant pleural effusion (MPE) is a common, serious problem predominantly seen in metastatic
lung and breast cancer and malignant pleural mesothelioma. Recurrence of malignant pleural effusion is common,
and symptoms significantly impair people’s daily lives. Numerous treatment options exist, yet choosing the most
suitable depends on many factors and making decisions can be challenging in pressured, time-sensitive clinical
environments. Clinicians identified a need to develop a decision support tool. This paper reports the process of co-
producing an initial prototype tool.
Methods: Creative co-design methods were used. Three pleural teams from three disparate clinical sites in the UK
were involved. To overcome the geographical distance between sites and the ill-health of service users, novel
distributed methods of creative co-design were used. Local workshops were designed and structured, including
video clips of activities. These were run on each site with clinicians, patients and carers. A joint national workshop
was then conducted with representatives from all stakeholder groups to consider the findings and outputs from
local meetings.
The design team worked with participants to develop outputs, including patient timelines and personas. These
were used as the basis to develop and test prototype ideas.
Results: Key messages from the workshops informed prototype development. These messages were as follows.
Understanding and managing the pleural effusion was the priority for patients, not their overall cancer journey.
Preferred methods for receiving information were varied but visual and graphic approaches were favoured. The
main influences on people’s decisions about their MPE treatment were personal aspects of their lives, for example,
how active they are, what support they have at home.
The findings informed the development of a first prototype/service visualisation (a video representing a web-based
support tool) to help people identify personal priorities and to guide shared treatment decisions.
(Continued on next page)
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Conclusion: The creative design methods and distributed model used in this project overcame many of the
barriers to traditional co-production methods such as power, language and time. They allowed specialist pleural
teams and service users to work together to create a patient-facing decision support tool owned by those who will
use it and ready for implementation and evaluation.
Keywords: Creative co-design, Co-production, Malignant pleural effusion, Decision support tool, Complex
intervention development
Background
Managing complexity in healthcare
Healthcare services are becoming increasingly complex.
Improving these services or systems can be difficult as
interactions between individual components are often
multi-faceted; changing one individual part of these
complex systems is unlikely to lead to meaningful
change overall [1, 2]. There is an increasing need to in-
volve patients and staff in the development of new inter-
ventions, to address the challenges complex problems
and systems present, to make them relevant and applic-
able in practice [3–5].
This paper describes a service improvement project to
design and develop a decision support tool: ‘my pleural
effusion journey’. This tool aimed to address the com-
plex problem of malignant pleural effusion (MPE) man-
agement. It involved patients and staff from three
specialist pleural clinics from across the UK and used
creative co-production as a means to achieve this. This
paper does not set out to provide any formal findings
from an evaluation of the tool. The purpose of this paper
is to reflect on the potential contribution of creative co-
production in the design and development of a complex
intervention for an exemplar health care problem.
Co-production and complex intervention development
Co-production has been growing in popularity over re-
cent years as it is recognised that traditional linear ap-
proaches to generating and mobilising evidence do not
always lead to changes in clinical practice or improved
care [4, 5]. Co-production involves all stakeholders (ser-
vice users and service providers) in the different stages
of the research / service improvement process and takes
into account local knowledge and context. It offers a
more holistic and nuanced approach to address the evi-
dence to practice gap than traditional research methods
[1, 3, 6]. Knowledge in all its forms (research and experi-
ential) is considered and blended to co-produce prac-
tical, contextually specific interventions that are owned
by those who will use them and are more likely to be
implementable in practice [7].
Co-production is a recognised method for complex
intervention development [2] and a recently published
taxonomy of approaches to developing interventions to
improve health includes it in its partnership category [8].
In decision support intervention development specific-
ally, it is now acknowledged that it is important to con-
sider patients’ perspectives as well as the scientific
evidence in content specification [9].
There is a lot of interest in co-production currently,
but a lack of criticality as to what the term means. There
are descriptions of the challenges of doing co-
production such as power [3, 10, 11], language [10] and
time [3, 11, 12], but no reports of practical attempts to
address these. However, Langley et al. have proposed a
framework that describes how creative methods address
these challenges [7]. The creative co-production re-
ported here is a practical response to the challenges
drawing on the practice of the User Centred Healthcare
Design and Translating Knowledge into Action themes
of the National Institute for Health and Research Collab-
orations for Leadership in Applied Health Research and
Care South Yorkshire (NIHR CLAHRC SY) and subse-
quently Yorkshire and Humber (YH).
A four phased process of creative co-production was
adopted in the service improvement project presented
here. The approach is based on the Better Services by
Design approach [13]. This is a human-centred process
of divergent and convergent thinking. It ensures all
forms of knowledge are recognised and defined in the
first stages. All ideas are considered in the latter stages
before the best or most practical solutions are tested
through an iterative prototyping process. The last phase
consists of delivering a final prototype ready for evalu-
ation and implementation [13] (Fig. 1).
Creative methods using visualisations and the making
of design artefacts within the workshops formed the
basis of our approach. These allow capturing the partici-
pant’s experience, knowledge, habits, behaviours and
ideas and promote a shared common language that
avoids professional jargon [7, 14]. The creative activities
enable participants to unlock tacit knowledge and turn
their ideas into real, visible and tangible objects that
show their suggestions have been valued, listened to and
acted upon [7, 10, 14].
The Translating Knowledge into Action (TK2A) theme
of the NIHR CLAHRC YH has been using and develop-
ing this approach over the past 10 years. The TK2A
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team has a unique combination of clinical researchers
and design researchers who have developed and now de-
liver this creative co-production approach. With both
clinical and designer perspectives, the creative co-
production approach is able to be flexible and responsive
throughout the process and allows for the consideration
of all aspects of the clinical service. Bringing together
the clinical and designer perspectives which guide those
of the participants ensures the methods fit the end goal
whilst remaining focused on the clinical problems at
hand.
This project aimed to develop a decision support tool
to address the complex problem of malignant pleural ef-
fusion (MPE) management and it exemplifies the value
of creative co-production methods.
The complex clinical problem
Malignant pleural effusion (MPE) is an accumulation of
fluid in the pleural space in the presence of malignant
cells or tumour tissue. It is a common, serious problem
predominantly seen in metastatic lung and breast cancer,
and commonly in malignant pleural mesothelioma [15].
Recurrence of MPE is common and symptoms, which
include breathlessness, pain, cough and reduced physical
activity, significantly impair people’s daily lives [15]. Des-
pite advances in the treatment of MPE, management re-
mains palliative, focusing on relief from symptoms in
order to improve quality of life. Prognosis is variable and
multi factorial but on average life expectancy after diag-
nosis is between 3 and 12 months [15].
There are a number of different treatment strategies
for malignant pleural effusion. There are clinical factors
that mean in certain scenarios some of these interven-
tions are not appropriate. In other scenarios all treat-
ment options are possible. When fluid has been
removed from the pleural space the key question is
whether the underlying lung then re-expands to its nor-
mal size, allowing contact with the inside of the chest
wall (‘expandable lung’).
If the lung is expandable then attempts at adhering the
lung to the chest wall may be appropriate, with the aim of
preventing re-accumulation of fluid in the future [16].
This procedure, called pleurodesis, can be achieved
through a number of methods: injecting a liquid slurry of
talc powder (which acts as a local irritant to cause inflam-
mation and adhesion) through a temporary chest tube
placed in the pleural space; directly spraying dry talc pow-
der during a video-assisted operation; or through a longer
term, tunnelled chest tube that remains in-situ for several
weeks or months whilst the patient goes about their nor-
mal day-to-day activities at home [16].
No one intervention has been proven to be more ef-
fective in terms of pleurodesis success [17, 18]. However,
from the subjective viewpoint of the patient, there are
potential positive and negative sides to each approach;
for example, the procedures involving talc require short
inpatient stays.
If the lung does not expand (non-expansile lung or
‘trapped lung’) then pleurodesis will not succeed and the
treatment options include repeated removal of fluid
(pleural aspiration) or tunnelled chest tube described
above, which is drained on a regular basis.
For all involved, this is a challenging area with a
number of complex medical concepts to explain to the
Fig. 1 Better Services by Design 4 phase approach
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patient. Additionally, patients with a MPE tend to
present with severe breathlessness, typically necessitating
urgent, often same-day intervention. This puts great
stress on the decision-making process which, for the pa-
tient would ideally include: understanding the concept
of the effusion; the different treatment options; and
which of these may be best suited to them at that par-
ticular time. Choosing which option is best for each pa-
tient depends on many factors [19]. It is in this setting
that there is an unmet need for a decision support tool,
one which can hopefully better support patients and cli-
nicians to make the most appropriate decisions.
Three pleural teams from across the UK had already
undertaken a body of work to explore the patient experi-
ence in this area, including an evidence review of MPE
treatment options, and qualitative patient and carer in-
terviews. This confirmed the need for better support for
patients in order to make the right choice regarding
their MPE treatment. Funding had been secured to de-
velop a decision support tool following a successful ap-
plication to an open call for applications from the North
West Lung Centre Charity at Wythenshawe Hospital.
However, further work was required to co-produce the
content and format of the decision support tool before
handing this to the software company to develop the
final product. This creative co-production project aimed
to undertake that co-production as a collaboration be-
tween the clinicians, patient and carers from three na-
tional centres and the TK2A team. Due to the distance
and ill health of the service users, a novel distributed
model of creative co-production was developed and
used. This article considers the contribution of creative
co-production techniques in developing a new interven-
tion (in this case a decision support tool) to address a
complex clinical situation.
Aims
The aim of this distributed creative co-production pro-
ject was to develop an initial prototype of a decision sup-
port tool for people with MPE, using participatory
methods and a patient-led approach. Future studies will
evaluate the clinical effectiveness of the tool.
Methods
This was a distributed creative co-production project.
Three clinical pleural teams were involved: St Thomas’
Hospital (London), Wythenshawe Hospital (Manches-
ter), and Southmead Hospital (Bristol). Creative co-
production workshops were conducted locally (distrib-
uted) with healthcare professionals, patients and their
carers from the three sites, and supported virtually by
the TK2A team. This was followed by a national work-
shop regrouping the core teams from the three sites.
Prototype development meetings were held via
teleconferencing to analyse and interpret insight gener-
ated by the workshops. The process was led by the
TK2A team of the NIHR CLAHRC YH using their cre-
ative co-production approach. A designer was integral to
the conduct of all stages, allowing developing of visual
design artefacts to support the process as well designing
the resultant prototype. As this project was classed as
service improvement, NHS ethical approval was not re-
quired. However ethical principles were considered
throughout the project and consent was obtained from
all participants prior to their participation in the
workshops.
Aims of the creative co-production workshops
Distributed creative co-production workshop
To understand the lived experience of malignant pleural
effusion and its management from both service user and
provider perspectives to gain a shared understanding of
the key issues to be addressed.
National creative co-production workshop
To develop ideas to support development of a MPE de-
cision support tool.
Sample
The distributed creative co-production workshops were
attended by clinicians, patients and carers from each
local site, as outlined in Table 1.
Table 1 Sample creative co-production workshops
Local distributed workshops
Site 1 Local facilitator (Consultant physician × 3)
5 x Patients
2 x Carers
Pleural physician
Clinical nurse specialist
Site 2 Local facilitator (Physician Registrar)
5 x Patients
3 x Carers
Consultant physician
Clinical nurse specialist
Clinical research nurse
Site 3 Local facilitator (Physician Registrar)
5 x Patients
4 x Carers
Senior research nurse
Student nurse
National workshops
TK2A team 2 x Facilitators (design researcher and clinical
researcher)
Clinical staff 2 x Consultants
3 x Registrars
3 x Nurses
Patients and
carers
2 x Patients
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The national creative co-production workshop partici-
pants were the 2 facilitators along with lay and clinical
representatives from the local, distributed workshops.
Data collection
Distributed creative co-production workshop
Due to the disparate locations and the ill health of the
patient participants, a distributed model of creative co-
production was adopted. This involved the TK2A team
preparing the materials and providing PowerPoint in-
structions folded into a step-by-step video for the local
facilitator on each site to conduct their creative co-
production workshop. The local facilitator was provided
with a detailed workshop schedule and copies of the re-
sources to be used in written, audio and video format
(Box 1). These were discussed prior to the workshop via
teleconference with the three local leads. The resources
were then refined and redistributed electronically to
allow time for the local facilitators to print and familiar-
ise themselves with the resources and activities they
would be carrying out with participants.
The workshop facilitator took participants through a
series of activities that considered their experiences of
living with and managing MPE (Fig. 2). This allowed
participants to gain a shared understanding of the chal-
lenges faced when giving and receiving information
about MPE treatment options from both clinical staff
and patient/carers perspectives. Each local workshop
started with a standardised slideshow and introduction
video which was pre-recorded by the TK2A team. In-
structions for the initial warm up activity which encour-
age participants thinking creatively were also provided
by a pre-recorded video. The local facilitators then
followed the workshop plan and carried out the activities
using printed versions of the resources provided.
Data was collected in the form of flip chart notes of
discussions, completed workshop resources and field
notes from facilitators. All these were sent to the TK2A
team for analysis and discussion in the prototype devel-
opment meetings.
National creative co-production workshop
The national workshop took place 4 weeks later in
London, with representatives from all clinical sites. Par-
ticipants included a range of clinical staff, the TK2A
team and two patients.
In this co-production workshop, a series of creative ac-
tivities were carried out by the participants, facilitated
this time by the TK2A creative co-design experts. At the
start of the national workshop each site was asked for
their key insights from their local workshop in relation
to the cancer journey, the MPE journey, MPE informa-
tion delivery and sparks/highlights. This allowed the
three teams to be able to see and discuss each other’s
key workshop findings as well as verify the analysis that
had been completed by the TK2A team remotely. The
national workshop activities were supported by re-
sources designed by the TK2A team (Fig. 3).
The national workshop enabled real time analysis and
visualisation of ideas to occur by the design and clinical
researchers present from the TK2A team. The creative
activities enabled the participants to consider the find-
ings from the first workshop and then explore the differ-
ent treatment options and clinical and patient
preferences. Personas were used to ensure the patient
voice remained central to the process. The personas
Box 1 Schedule for the local distributed creative co-production workshop and national workshop
Workshop Schedule
Local, distributed workshops • PowerPoint presentation and video: welcome and introduction
• Warm up exercise
• Patient journey exercise
• Discussion
• Pleural effusion timeline exercise
• Discussion
• Pleural effusion experience exercise
• Discussion
• Pleural effusion information exercise
• Discussion and close
National workshop • Welcome and introduction
• Warm up exercise
• Feedback from local workshops
• Discussion
• Developing personae
• Discussion
• Working with personae to identify decision making journey and information needs
• Discussion
• Decision support tool content and format
• Discussion and close
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Fig. 2 Distributed creative co-production workshop resources
Fig. 3 Creative co-design activities
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were developed by the workshop participants and were
used to generate ideas about the decision support tool.
Prototype development meetings
Prototype development meetings occurred at key stages
throughout the process; these were:
 prior to the local distributed workshops
 following analysis of the data from the local
workshops
 prior to the national workshop
 following analysis of the data from the local
workshops
 following initial decision support tool prototype
design to inform refinement
 at the end of the project to finalise the decision
support tool prototype to send to the software
company for development
Participants were the clinical lead for each site plus
the TK2A team. All these meetings were conducted via
teleconferencing. Notes on design discussions and deci-
sions were recorded as data.
Data analysis
Analysis of the data was iterative. It occurred throughout
the process with findings informing the subsequent
stages in the process of decision support tool
development.
The local facilitators at each of the distributed work-
shops sent their completed resources back to the TK2A
team electronically. The data was analysed after the
workshops by the clinical and design researchers who
had not been present at the workshops. Key themes and
trends were identified by the TK2A team from the data
separately for each of the three sites. These findings
were discussed in a prototype development meeting to
generate consensus regarding their meaning. The impli-
cations of the data for the decision support tool were
considered. Resources were then developed for the na-
tional workshop based on these findings.
Analysis of activities in the national workshop used
the same approach as per local meetings.
Further analysis of the final ideas from the national
workshop was carried out by the TK2A team post
workshop.
Findings
The key experience-based findings from the workshops
were summarised as follows:
The distributed creative co-production local workshops
1. Patients were more concerned about the management
of the symptoms of MPE as an immediate priority rather
than their overall cancer treatment. This was due to the
life limiting symptoms MPE causes.
2. People with MPE would prefer to receive informa-
tion regarding treatment options in a timely manner,
preferably by a specialist pleural team, and in a variety of
formats including verbal, written and animation. How-
ever, visual information was of key importance to facili-
tate understanding of their MPE and therefore decision
making. If advice from a specialist pleural team were not
possible, then information should be provided in a con-
sistent manner from other health professionals (e.g. phy-
sicians, oncologists, nurses).
3. If sign-posting was to occur, it needed to come from
a reliable source (e.g. cancer charity websites like Mac-
millan or Mesothelioma UK).
4. Any information resource that supported treatment
decisions needed to be available to people with MPE and
their carers at key moments throughout their cancer
journey.
Positive feedback was received regarding the distrib-
uted workshops themselves. One workshop participant
(a student nurse) described the process of being able to
hear the perspective of someone living with MPE as ‘the
best learning experience of their training to date‘.
The joint national workshop
The findings from the joint national workshop provided
vital understanding of what the content and format of
the decision support tool needed to be. The workshop
findings indicated that the main influences on people’s
decisions about their MPE treatment were:
1. Personal aspects of their lives (e.g. how active they
are, what support is available at home);
2. Emotional and practical support such as support
regarding worries, concerns and fears about
treatment options.
3. Perceptions of underlying health, and ability to
endure treatments and pain.
These were embodied in the prototype tool by prompt
questions.
A clear message was that there is no ‘one size fits all’
solution for MPE management. Therefore, these factors
that would facilitate access or appropriateness of differ-
ent treatment options were made part of the prototype
tool. Participants agreed that the decision support tool
itself needed to be available in different formats to en-
sure its accessibility for a range of patients, regardless of
their age, level of social support or distance from the
hospital - factors identified as important in the work-
shops. A website platform seemed to be the most ac-
ceptable and accessible format. However, this was
Grindell et al. BMC Medical Informatics and Decision Making          (2020) 20:179 Page 7 of 12
conditional on supporting information being available
supplied by healthcare staff in the clinical environment.
Consensus was reached regarding the key content for
the web-based decision support tool (Box 2). Recom-
mended content included information about what a
pleural effusion is, its cause, treatment options and
implications.
The TK2A team used these findings to develop a first
prototype in the form of a video representation of an on-
line decision support aid. This showed that:
1. People with MPE could access the decision support
tool from home via a tablet or laptop computer
prior to coming to their hospital appointment. It
could therefore be used by people in preparation for
a clinic appointment, and in associated discussion
of treatment options.
2. It could also be used as a support tool within a
healthcare appointment. The latter was important if
the tool was going to be used by people who could
not use technology themselves due to illness,
disability or preference.
The developed tool gives patients and carers informa-
tion regarding the treatment options and helps them de-
cide the most suitable option for them. It also takes into
consideration the key influencing factors identified
through the creative co-production process. These fac-
tors related to personal circumstances such as their tol-
erance to pain, how close they live to the hospital and
whether they were happy to self- manage. The video was
sent to the three participating pleural teams who were
invited to give initial feedback prior to a teleconference
to further discuss it in more depth. To facilitate remote
conversation, slides of the website were produced
(Fig. 4).
Prototype 1 received positive feedback. However, there
were concerns that the tool content could be interpreted
as prioritising one treatment over another without allow-
ing for discussion with a consultant.. Following this feed-
back, a second iteration of the video prototype was
developed by the TK2A team incorporating a traffic light
system (favoured by some of the clinicians in the work-
shops) which allowed the patient to see which treat-
ments were available to them based on their personal
circumstances (Fig. 5).
Further teleconference discussion took place between
the TK2A team and the three pleural teams. Once the
core structure and the visual representation were re-
fined, the pleural teams were tasked with writing the
clinical content and gathering patient stories. The con-
tent along with the video representation was then passed
on to a software company who have developed a web
based version of the tool ready for testing. This can be
found at https://mypleuraleffusionjourney.com [20].
Discussion
It is known that the implementation of evidence, into
clinical practice is challenging [3, 5]. It is recognised that
involving service users and providers in the evidence
generation and intervention development process can
help to overcome some of the problems faced compared
to more traditional linear methods [3–5]. Co-production
is growing in popularity as a way to engage service users
and providers in applied health care research to help
bridge the knowledge to practice gap [3–5] and help re-
duce research waste [8]. However, it is used in many dif-
ferent ways and not always described adequately in the
literature [21]. This project describes a distributed form
of co-production using creative co-design methods to
address the challenge of co-creating a practical, context-
ually specific decision support tool for the management
of MPE.
Creative co-design
The creative and prototype development activities
adopted in this project proved successful in co-creating
a prototype complex intervention. The process overcame
some of the common barriers to co-production in
healthcare, namely, power, language and time. They also
enabled a participatory approach to content specification
in decision tool design and development as recom-
mended by Elwyn et al. [9]
The participants in this project engaged in ‘making’
through creative activities in order to explore and reflect
on their experiences; this helped to address to some ex-
tent the barriers of power and language. The creative ac-
tivities enabled them to share and express themselves in
an inclusive environment using a common language [7,
10]. It has been proposed that co-production activities
that promote inclusivity and the development of mean-
ingful, egalitarian partnerships between participants,
unlocking tacit knowledge and encouraging different
ways of thinking, can lead to more useful and implemen-
table solutions [6, 7, 21].
The prototype decision support tool took the form of
a visual representation of a web-based intervention but
in video format. The short video included commentary
through each screen allowing participants to get a feel for
what the resource could be like and contain without
Box 2 Core content for a MPE decision support tool
1) What is a pleural effusion?
2) Why it happens and what causes it.
3) General terminology and goals of treatment.
4) Details of the different treatment options.
5) What’s important to me (the person with MPE).
6) Further support in the form of trouble shooting, patient stories and
links to other resources.
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having to wade through pages of descriptive text. This
allowed everyone involved, regardless of profession or lit-
eracy, to be able to understand the concept of the pro-
posed decision support tool. This visual technique is one
that is recommended and often deployed in the creative
design phase of web-based decision tool development [9].
Basing the co-production process on design principles
encouraged a solution-focused approach and gave par-
ticipants the permission to think beyond the usual con-
straints of their working environment. Having a design
facilitator enabled visualisation of thoughts and ideas as
they arose. This allowed real time synthesis of occurring
knowledge, for example through drawings, which was
presented in a form that was easy to understand and
which accurately represented participant’s views [7].
Design prototyping is still not commonly used in a
health care context, although it is starting to gain atten-
tion [5–7]. Prototyping in this study turned participants’
ideas into something tangible that helped generate more
useful and practical feedback to drive the idea forward
Fig. 5 Prototype 2
Fig. 4 Prototype 1
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[6, 7]. Expense is always a factor when developing and
designing interventions in health care. This study demon-
strated that initial prototypes that aim to generate useful
feedback do not need to be highly polished, expensive
products [7]. When prototyping, Bec et al. argue that de-
signers constantly have to make compromises about the
level of fidelity of the prototype to make based on the
available resources (e.g. time, money) and the type of feed-
back sought [22]. In this study, the use of low fidelity pro-
totypes, that are quick, easy and cheap to make, allowed
iterative cycles of feedback and development to occur.
This co- created, visible and tangible object (a video repre-
sentation in this case) is a physical embodiment of partici-
pants’ ideas and demonstrates that their suggestions have
been valued, listened to and acted upon and therefore give
them a sense of ownership [6, 7, 10]. This process of cre-
ative co-production from which the prototypes emerged,
an online decision support tool in this case, mean that the
final product is more likely to be implementable [7].
Distributed model of creative co-production
Using a distributed creative co-design approach enabled
the project to bring together three disparate teams and
enabled the voices of all stakeholders to be heard.
Hence, barriers such as time, geographical distance and
poor health of service users could be overcome. The ini-
tial distributed workshops ensured the lived experiences
of all stakeholders (service users and providers) were ex-
plored allowing a synthesis of evidence (experiential and
research) to occur to inform the content specification
phase of the decision tool development. Different per-
spectives were shared through the creative resources
prepared by the specialist TK2A team. It might be ar-
gued that other methods of co-production could have
delivered similar results. Examples include experience-
based co-design which has an online toolkit of resources
for local facilitators to use to deliver their own co- de-
sign workshops [23]. However, the benefits of having
workshop activities and resources that are designed
within the project, bespoke to the participants’ experi-
ences proved successful here. These were prepared by
design and clinical researchers with expertise in the use
of the creative co-production techniques, following con-
sultation with the specialist sites, with clear instructions
that were written, verbal and visual (via paper, Power-
Point and video), which enabled more meaningful and
engaging activities to be developed. This also saved busy
clinicians (who acted as local facilitators) invaluable time
as they did not have to plan and prepare the workshop
themselves.
In this project the distributed creative co-production
workshops were facilitated by local leads but planned
and designed by design and clinical researchers. The
level of involvement of the designer was significant and
embedded at every stage. This genuine collaboration
with designers allowed techniques such as drawing and
making to be adopted as and when they were most fruit-
ful, not just in the creative design phase of decision tool
development as suggested by Elwyn et al. [9].
The distributed model of local and national workshops
and the prototype development meetings enabled every-
one that had been involved in the creative co-production
process to remain involved throughout the project. The
prototype could be viewed and feedback reviewed elec-
tronically (and via the prototype development teleconfer-
ence meetings) without physically having to bring the
three disparate groups of participants back together
again in one place. It is unlikely that the feedback and
subsequent prototype iterations would have developed
in the same way without the sustained engagement of
the participants from the three sites. Sustained inclusion
in co-production is recognised as being difficult [21].
The distributed model of creative co-production suc-
cessfully overcame some of the difficulties often experi-
enced with recruitment, retention and sustained
involvement of participants in the co-production
process. It also saved valuable clinical time for the health
professionals involved.
Limitations of the study
This study describes the creative co-design methods
used to develop a prototype decision support tool for
the management of MPE only. The effectiveness of the
intervention is not certain as no evaluation of the proto-
type in the clinical setting has yet been undertaken.
However, the decision support tool has now been devel-
oped by a software company and funding is being sought
to evaluate the prototype tool.
One limitation of the project was the small number of
patients who had input across the study process. This
was due to their ill health, which meant their input di-
minished beyond the first local workshops. However,
this was pre-empted and addressed to some degree by
the use of personas to represent the characteristics of a
broad range of MPE patients to ensure their needs were
considered throughout the creative co-production
process. The personas used in the national workshop
and throughout the prototype development were
grounded in the patient experiences shared in the local
workshops.
Co-production techniques are often criticised for their
lack of generalisability. The findings from the workshops
and the subsequent developed prototype decision tool
were never intended to be generalisable beyond the local
context within which they were co-created. That said,
this was a national service improvement project involv-
ing three separate pleural teams in the UK; hence it
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could be argued, due to the multi-site involvement, the
resultant prototype is more generalizable.
Finally, creative co-production is a resource intensive
approach. The distributed model used in this project
provided an efficient approach to prototype development
and reduced the impact of participation to some degree
on patient and clinician time.
Implications for future co-production of complex
interventions
The creative co-design methods used in this project at-
tend to the development stage of the complex interven-
tion development process [2] and fit both within the
recent taxonomy of recommended approaches [8], and
the process map for decision tool design and develop-
ment recommended by Elwyn et al. [9]. It is recognised
that involving appropriate stakeholders throughout the
complex intervention development process, taking ac-
count of context and considering practicalities of imple-
mentation early on in the process, is likely to lead to
more relevant and successful change in practice [2, 8].
However, there are many practical barriers in projects
requiring such an inclusive approach. The distributed
creative co-production approach could provide a useful
way of overcoming those obstacles.
This project involved clinical and design researchers
working together with all relevant stakeholders. This led
not only to a blurring of traditional academic and practice
boundaries, but also, through the addition of the practical
and pragmatic contribution of design, to the engagement
of users and carers in the creation of a complex interven-
tion. This shared understanding and knowledge was used
to co-create a practical and contextually specific solution
to the complex problem of MPE management ultimately
owned by those that created it. This approach therefore
has the potential to address, understand and overcome
common implementation challenges.
The distributed method used in this project has impli-
cations for future use of co-production in health care. It
enabled multi-site involvement and a more flexible ap-
proach in terms of workshop planning, facilitation and
prototype development.
Conclusion
Creative co-production and the distributed method used
in this service improvement project have many strengths
compared to more traditional approaches to knowledge
synthesis and complex intervention development. The
approach attends to the challenges of power, language,
and time which are recognised barriers to the achieve-
ment of successful change in healthcare as well as fitting
within the suggested process map for decision tool de-
sign and development. Some might argue that this ap-
proach does not fulfil the needs of academic rigour or
produce generalizable solutions. Nonetheless, the atten-
tion to context and the production of a prototype in-
formed by the needs of those who will use it leads to
more practical, fit for purpose interventions that are
more likely to be usable in practice. Further research
into both the distributed and creative co-production ap-
proaches is therefore warranted to critically examine
their merit in complex intervention development and
service improvement.
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